← back to search

Zhuoya Jia

Hebei Medical University · CN
Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Diabetes Treatment and Management, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer, and Vitamin D Research Studies.
h-index
9
citations
203
works
16
NIH funding
primary concept
email

Recent publications

Corrigendum to “A metabonomics-based renoprotective mechanism analysis of empagliflozin in obese mice” [Biochem. Biophys. Res. Commun. 621 (2022) 122–129]
Biochemical and Biophysical Research Communications 2025cited by 0position: middledoi
Effect of High‑Fat-Diet and Semaglutide on Bladder Cancer in Mice
Research Square 2024cited by 1position: middledoi
The Relationship Between Non-HDL-C /HDL-C Ratio (NHHR) and Vitamin D in Type 2 Diabetes Mellitus
Diabetes Metabolic Syndrome and Obesity 2023cited by 35position: middledoi
Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
Frontiers in Pharmacology 2023cited by 26position: middledoi
Correlation Between Fibrinogen/Albumin and Diabetic Peripheral Neuropathy
Diabetes Metabolic Syndrome and Obesity 2023cited by 12position: middledoi
Association Between Vitamin D Levels and the Atherogenic Index of Plasma Among Chinese with Type 2 Diabetes Mellitus
Diabetes Metabolic Syndrome and Obesity 2023cited by 2position: middledoi
Mechanisms of Small Intestine Involvement in Obesity-Induced Atherosclerosis
Diabetes Metabolic Syndrome and Obesity 2023cited by 2position: middledoi
Single-cell transcriptomics identifies Col1a1 and Col1a2 as hub genes in obesity-induced cardiac fibrosis
Biochemical and Biophysical Research Communications 2022cited by 32position: middledoi
UTP14A, DKC1, DDX10, PinX1, and ESF1 Modulate Cardiac Angiogenesis Leading to Obesity-Induced Cardiac Injury
Journal of Diabetes Research 2022cited by 18position: middledoi
Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
Drug Design Development and Therapy 2022cited by 14position: middledoi
Effect of high-fat diet and empagliflozin on cardiac proteins in mice
Nutrition & Metabolism 2022cited by 13position: middledoi
Single-cell transcriptome reveals effects of semaglutide on non-cardiomyocytes of obese mice
Biochemical and Biophysical Research Communications 2022cited by 10position: middledoi
A metabonomics-based renoprotective mechanism analysis of empagliflozin in obese mice
Biochemical and Biophysical Research Communications 2022cited by 9position: middledoi
The Correlation Between Estimated Glucose Disposal Rate and Coagulation Indexes in Type 2 Diabetes Mellitus
Diabetes Metabolic Syndrome and Obesity 2022cited by 4position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jiangli Ban · Hebei Medical University13 papers (2022–2025)Ruoxi Zhen · Hohai University13 papers (2022–2025)Zelin Li · Yunnan Academy of Agricultural Sciences11 papers (2022–2025)Shu Niu · Hebei Medical University9 papers (2022–2025)Xiaoyu Pan · Hebei Medical University9 papers (2022–2025)Qingjuan Ren · Hebei Medical University8 papers (2022–2025)Lin Yue · Hebei Medical University8 papers (2022–2023)Xing Chen · Hebei Medical University8 papers (2022–2025)Ruiyi Zhu · Hebei Medical University8 papers (2022–2025)Xiaoyi Chen · Hebei Medical University7 papers (2022–2025)Shuchun Chen · Hebei Medical University7 papers (2022–2023)Shuchun Chen · Hebei Medical University7 papers (2022–2025)Yanhui Liu · First Affiliated Hospital of Hebei Medical University1 papers (2024–2024)Lin Yang · Guangzhou University of Chinese Medicine1 papers (2024–2024)Yanhui Liu · Shihezi University1 papers (2023–2023)Xueqing Zhang · Nanjing University of Chinese Medicine1 papers (2023–2023)Yue Lin · Hebei Medical University1 papers (2025–2025)Liqun Yang · Hebei General Hospital1 papers (2023–2023)Xiaoyu Pan · Xinjiang University1 papers (2023–2023)Cuijuan Qi · Hebei General Hospital1 papers (2022–2022)